I co-lead a cannabis research program focused on innovative trials to explore both positive and negative effects of cannabinoids on health and well-being. Our human experimental research provides key insights into which populations are most at risk and how informed cannabis use can maximize benefits. As part of this, we launched the Biobank ACCES, which stores biological samples alongside sociodemographic and clinical data. 

Our program also includes the development of cannabis harm-reduction e-interventions, a cannabinoid testing and analysis platform, longitudinal public health surveillance projects, and a clinical research coordination centre for multisite intervention trials for substance use and its psychiatric comorbidities. 

Additionally, we developed the Expertise and Collaboration Centre for Concurrent Disorders (CECTC), a knowledge-sharing platform that addresses addiction and mental health services. We assist professionals and organizations across Quebec in implementing sustainable, integrated care tailored to the needs of individuals with concurrent disorders.